What is it about?
Discussion and projection of Bangladesh pharma market in a multi-dimensional approach. Methodology: Inclusive data collection from newspapers, journals, newsletters, news reports and updates. The true focus was on historical data collection, current market scenario, projections by experts in related fields, drug dealers, mergers and acquisitions, market trend analysis reports and newer development prospects
Featured Image
Photo by freestocks.org on Unsplash
Why is it important?
Along with students, researchers and professionals of different background and disciplines, e.g. Pharmacists, marketers, finance companies and regulatory authorities have to acquire much from this article.
Perspectives
Bangladesh pharma market has tremendous hope, although going through lots of anomalies. Reasons behind are economic development, population blast, investment scopes, FDIs along with many other unexplained matters. By next decade, Bangladesh is aiming to 30 world class drug manufacturers to establish strong footstep in global pharma market. Bangladesh, as an LDC got exempted from the obligation of patent and data protection in this arena until 2033. Interestingly, Bangladesh already passed across the LDC landmark to a developing country. So, there’s window of opportunity of more than a decade to grow further from that aspect.
Mr. Abdul Kader Mohiuddin
Read the Original
This page is a summary of: An A-Z of Pharma Industry Review: Bangladesh Perspective, Pharmatutor, December 2018, PharmaTutor Edu Labs,
DOI: 10.29161/pt.v6.i12.2018.64.
You can read the full text:
Contributors
The following have contributed to this page
